Heartbeam Inc. (BEAT) Financial Statements (2025 and earlier)

Company Profile

Business Address 2118 WALSH AVE., SUITE 210
SANTA CLARA, CA 95050
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:9,157,00012,638,00016,189,00019,200,00021,300,000990,000
Cash and cash equivalents9,157,00012,638,00016,189,00019,184,00017,401,000990,000
Other undisclosed cash, cash equivalents, and short-term investments    16,0003,899,000 
Debt securities, held-to-maturity, excluding accrued interest, after allowance for credit loss  3,939,151 
Other undisclosed current assets544,000599,000636,000279,000(3,607,151)471,000
Total current assets:9,701,00013,237,00016,825,00019,479,00021,632,0001,461,000
Noncurrent Assets
Property, plant and equipment370,000344,000256,000144,000  
Other noncurrent assets55,00054,00050,00025,000  
Total noncurrent assets:425,000398,000306,000169,000  
TOTAL ASSETS:10,126,00013,635,00017,131,00019,648,00021,632,0001,461,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,420,0001,097,0001,194,0001,019,000570,0002,320,000
Other undisclosed accounts payable and accrued liabilities1,420,0001,097,0001,194,0001,019,000570,0002,320,000
Total current liabilities:1,420,0001,097,0001,194,0001,019,000570,0002,320,000
Noncurrent Liabilities
Total liabilities:1,420,0001,097,0001,194,0001,019,000570,0002,320,000
Equity
Equity, attributable to parent8,706,00012,538,00015,937,00018,629,00021,062,000(859,000)
Common stock3,0003,0003,0003,0003,0001,000
Additional paid in capital55,090,00053,966,00052,759,00051,572,00050,535,00025,462,000
Accumulated deficit(46,387,000)(41,431,000)(36,825,000)(32,946,000)(29,476,000)(26,322,000)
Total equity:8,706,00012,538,00015,937,00018,629,00021,062,000(859,000)
TOTAL LIABILITIES AND EQUITY:10,126,00013,635,00017,131,00019,648,00021,632,0001,461,000

Income Statement (P&L) (USD)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Operating expenses(5,090,000)(4,784,000)(4,109,000)(3,737,000)(3,312,000)(4,156,000)
Operating loss:(5,090,000)(4,784,000)(4,109,000)(3,737,000)(3,312,000)(4,156,000)
Nonoperating income134,000178,000230,000267,000158,00020,000
Net loss available to common stockholders, diluted:(4,956,000)(4,606,000)(3,879,000)(3,470,000)(3,154,000)(4,136,000)

Comprehensive Income (USD)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net loss:(4,956,000)(4,606,000)(3,879,000)(3,470,000)(3,154,000)(4,136,000)
Comprehensive loss, net of tax, attributable to parent:(4,956,000)(4,606,000)(3,879,000)(3,470,000)(3,154,000)(4,136,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: